Skip to main content

NIPT Market Expected to Reach $10.82 Billion By 2030

 

Technological advancements in the healthcare industry have always played a crucial role in its overall development. The recent advancements in the life science industry, such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing, and molecular research, have opened up new and promising pathways to combat genetic diseases and reduce the overall global economic burden. Several conglomerate companies and start-ups, including Illumina, Inc., F. Hoffmann-La Roche AG, and Diagnomics Inc. based in the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada have been making significant investments in the fields of life sciences to develop promising gene sequencing-based non-invasive diagnostic procedures to promote global health. Among the innumerable advancements witnessed by the industry, non-invasive prenatal testing (NIPT) today stands as one of the most distinctive technologies in curbing the concerns related to genetic diseases.

Prenatal testing is undertaken before the birth of the child to identify chromosomal abnormalities in the fetus, which are at high risk of developing such abnormalities. Prenatal testing comes under the purview of antenatal care”. It involves various techniques and methods which can detect numerous genetic disorders present in the fetus and health problems in pregnant women. These genetic disorders, many of which are inherited, are dominant X-linked autosomal recessive disorders, which are easy to be detected in both conditions: prior to pregnancy and during pregnancy. It has been estimated that at the maternal age of 30 years, the risk of chromosomal abnormality increases approximately to 1/385 live birth rate.

As per BIS Research analysis, the global NIPT market was valued $2.18 billion in 2019, and is expected to reach $10.82 billion by 2030. The growth is attributed to the increasing reimbursement policies and insurance coverage across the globe. Further, the continued significant investments for genome sequencing by healthcare companies to meet the industry demand and growing incidence of genetic disorders are the prominent factors propelling the growth of the global NIPT market. 


Comments

Post a Comment

Popular posts from this blog

Understanding How the Human Centric Lighting Market is Segmented

Lighting plays a significant role in the lives of people, it has the potential to bring about positive changes in people’s behaviour. In the year 1989, a research was carried out and it proved that natural daylight can trigger the production of melatonin and serotonin, two of the most important hormones in the human body. These two hormones are responsible for inducing peaceful sleep and happiness in people. This led to the research and development in the field of human centric lighting (HCL). According to a report published by the BIS Research , the HCL market is expected to grow at a CAGR of 37.2% and 35.2% both in terms of volume and value during the forecast period (2018 – 2024). The HCL is segmented by the component, end-user and by region. Request the Sample: Human Centric Lighting Market The human centric lighting market can be further segmented by component, type, end-users, and region. The components or the controls are further segmented as microprocessors & microco...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more

Global Surgical Robotics Market: Analysis and Forecast, 2018-2025

Global Surgical Robotics Market: Focus on Products and Services (Surgical Systems, Instruments & Accessories, and Services & Maintenance), Applications, End Users, and Competitive Landscape: Analysis and Forecast, 2018-2025. Rising incidences of colorectal cancer, neurological disorders, interventional cardiology disorders and gynecological diseases, growing geriatric population, and active participation of the government and the industry players in the technological advancement in the field of computer assisted robotic surgeries have boosted the overall growth of this market. Another factor which significantly contributes to the revenue generation of a company is the recurring sale of equipment and accessories of a surgical system. The surgical robotics vendors generate revenue through one time sale of the surgical system and generate the recurring  revenue from the sale of equipment and accessory products and maintenance services used in the surgical system. A...
1 comment
Read more